Antidote Match
Smart search engine connecting patients with clinical trials
Platform · Cloud SaaSCompany source
Company profile
About Antidote
Antidote Technologies is a precision recruitment company on a mission to catalyze medical innovation by successfully connecting patients and researchers. The company addresses a critical problem in medical research: more than 80% of clinical studies are delayed due to lack of participants. Antidote solves this through two complementary approaches. For pharmaceutical sponsors and life science companies, they provide precision recruitment services using digital marketing, AI-powered patient matching, and a network of 300+ healthcare partners to accelerate enrollment. For patients, they've built the Match search engine—a smart platform that makes finding relevant clinical trials easy and accessible. The company brings together professionals with pharmaceutical, technology, business, and public health backgrounds to achieve their mission. Antidote operates with a patient-first mindset and maintains strong commitments to diversity, equity, and inclusion in clinical trial populations, as well as environmental, social, and corporate governance. They've received the Silver Award from Ecovadis for two consecutive years, placing them in the top 25% of companies assessed for corporate social responsibility. Through partnerships with organizations like JDRF, MSAA, BrightFocus Foundation, Beyond Type 1, and Melanoma Research Alliance, Antidote provides dynamic content and trial search tools to patient communities while helping researchers find the volunteers they need for breakthrough treatments.
Company description Antidote official website
Primary marketClinical Trials & Research
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at Antidote?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- Cardiometabolic conditions
- Hypertension
- Lung Cancer
- Melanoma
- Multiple Sclerosis
- Obesity
- Type 1 Diabetes
Who it serves
- Clinical research organizations
- Health nonprofits
- Life science companies
- Patient advocacy groups
- Pharmaceutical companies
Deployment & integration
Cloud Saas deployment with recorded integration context.
Recorded integration context: SEQSTER.
Geographic context
MarketsEuropean Union · United States
Company sourceOfficial website
Company milestones
Platform expansion
Partnership with SEQSTER announced in 2024 for patient matching and real-time data access. Launched first-ever Spanish-language clinical trial search engine for type 1 diabetes with Beyond Type 1 and JDRF. Received Ecovadis Silver Award for two consecutive years (2022, 2023).
Partnerships
Recorded partners
- Beyond Type 1
- BrightFocus Foundation
- JDRF
- Melanoma Research Alliance
- MSAA (Multiple Sclerosis Association of America)
- SEQSTER
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
Enterprise Match
Precision recruitment services for clinical trial sponsors
Service · Cloud SaaSCompany source
Market Feasibility
Real-world insights testing patient reach and qualification before study launch
Service · Cloud SaaSCompany source
Media Capabilities
Digital marketing and patient engagement campaigns for clinical trials
Service · Cloud SaaSCompany source
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
Autopalmitoylation of IDH1-R132H regulates its neomorphic activity in cancer cells.Nature chemical biology · Jul 1, 2026
Feasibility of a decentralised trial of sleep apnoea screening in patients with atrial fibrillation.Danish medical journal · Oct 2, 2025
Surgical treatment of breast fibroadenomas.Danish medical journal · Sep 9, 2025
Opioid and benzodiazepine use among adolescents and young adults in Denmark.Danish medical journal · Jul 8, 2025
SQL on FHIR - Tabular views of FHIR data using FHIRPath.NPJ digital medicine · Jun 9, 2025
Uncovering gaps in management of vasomotor symptoms: findings from a national need assessment.Journal of osteopathic medicine · Jan 1, 2025
Clinical validation
Clinical-trial records
Pilot of Training on 988 and NarcanNCT07072819 · Mentioned · COMPLETED
Rivastigmine for Antimuscarinic DeliriumNCT06382649 · Mentioned · RECRUITING
Rivastigmine as an Antidote for Clozapine and Other Anticholinergic-Induced CNS Depression and Delirium: A Study of 100 CasesNCT07545382 · Mentioned · COMPLETED
Administering Atropine Through Autoinjectors Within Ambulance Services for Poisoning Patients in Sri Lanka's North Central ProvinceNCT07581301 · Mentioned · NOT YET RECRUITING
Andexanet Alfa: Non-interventional Study in Stroke Units in Germany (DE)NCT05127941 · Mentioned · COMPLETED
The Effectiveness of CFT for Reducing Self-criticism in Patients With Complex PTSD: a Single-case Experimental StudyNCT05791760 · Mentioned · COMPLETED
Regulatory
Regulatory records
No linked records are currently available.
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
80% of medical research delayed due to lack of participants
Problem statement Antidote addresses
300+ healthcare partners
Partner network for patient reach
Top 25% of 90,000 companies
Ecovadis Silver Award for CSR commitment
Beyond Type 1
Launching Spanish-language clinical trial search for type 1 diabetes patients
First-ever Spanish-language T1D clinical trial search engine launched
BrightFocus Foundation
Providing families with clear, reliable information on clinical trials and accelerating path to new treatments
Recognized as tremendous resource for connecting families with clinical trial information
JDRF (Juvenile Diabetes Research Foundation)
Helping researchers find volunteers for type 1 diabetes trials and connecting T1D community with research opportunities
Launched first-ever Spanish-language clinical trial search engine for type 1 diabetes
Melanoma Research Alliance
Enhancing clinical trial search capabilities for people impacted by melanoma
Successfully partnered to improve trial access for melanoma patients
Multiple Sclerosis Association of America (MSAA)
Providing MS community access to clinical trial matching and resources to expedite MS research
Successfully integrated Antidote Match search tool to connect MS patients with appropriate clinical trials
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Updates from Antidote
Recent articles published on Antidote's official website.
Neurology Enrollment: Why sites miss dates even if willing patients are willing to enroll
Read on AntidoteWhy Do Clinical Trials Keep Adding Recruitment Tools Without Fixing Enrollment?
Read on AntidoteHow to Fix Clinical Trial Recruitment Bottlenecks
Read on Antidote15 clinical trial patient recruitment companies (and how to choose one)
Read on AntidoteWhat is RTSM (formerly IWRS) in clinical research?
Read on Antidote07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Clinical Trials & Research
Companies using AI to optimize clinical trial design, accelerate patient recruitment, match patients to trials, predict trial outcomes, or improve clinical research efficiency. Includes patient enrollment and screening platforms, AI-powered trial matching, and tools that reduce the time and cost of bringing new treatments to market.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.